AKT2 (AKT serine/threonine kinase 2)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
208 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
AKT serine/threonine kinase 2 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
AKT2 |
SynonymsGene synonyms aliases
|
HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA |
ChromosomeChromosome number
|
19 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
19q13.2 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains, which is involved in signaling pathways. The gene serves as an oncogene in the tumorigenesis of cancer cells For example, its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins, and has also been implicated in insulin signaling. [provided by RefSeq, Nov 2019] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs121434593 |
C>T |
Pathogenic |
Coding sequence variant, missense variant |
rs387906659 |
C>A,T |
Pathogenic |
Stop gained, coding sequence variant, missense variant, 5 prime UTR variant |
rs778561687 |
C>A,T |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1057519754 |
T>C |
Likely-pathogenic |
Coding sequence variant, intron variant, missense variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
miRTarBase ID |
miRNA |
Experiments |
Reference |
MIRT000425 |
hsa-miR-184 |
qRT-PCR, Luciferase reporter assay, Western blot |
20409325 |
MIRT000425 |
hsa-miR-184 |
PAR-CLIP |
20371350 |
MIRT000425 |
hsa-miR-184 |
Luciferase reporter assay, qRT-PCR |
27418134 |
MIRT006104 |
hsa-miR-203a-3p |
Northern blot, qRT-PCR, Western blot |
21354697 |
MIRT006473 |
hsa-miR-708-5p |
Luciferase reporter assay, qRT-PCR |
22552290 |
MIRT022768 |
hsa-miR-124-3p |
Microarray |
18668037 |
MIRT022768 |
hsa-miR-124-3p |
Immunoblot, Luciferase reporter assay, qRT-PCR, Western blot |
27175587 |
MIRT031019 |
hsa-miR-21-5p |
Western blot;Other |
20048743 |
MIRT036081 |
hsa-miR-1296-5p |
CLASH |
23622248 |
MIRT036895 |
hsa-miR-877-3p |
CLASH |
23622248 |
MIRT037571 |
hsa-miR-744-5p |
CLASH |
23622248 |
MIRT042572 |
hsa-miR-423-3p |
CLASH |
23622248 |
MIRT045569 |
hsa-miR-149-5p |
CLASH |
23622248 |
MIRT053175 |
hsa-miR-612 |
Immunofluorescence, Luciferase reporter assay, Western blot |
24704424 |
MIRT053175 |
hsa-miR-612 |
Immunohistochemistry, Luciferase reporter assay, qRT-PCR, Western blot |
23478189 |
MIRT053175 |
hsa-miR-612 |
Luciferase reporter assay, qRT-PCR, Western blot |
26158514 |
MIRT054191 |
hsa-miR-29a-3p |
Immunofluorescence, Immunohistochemistry, Luciferase reporter assay, Northern blot, qRT-PCR, Western blot |
25428377 |
MIRT054191 |
hsa-miR-29a-3p |
Flow, Luciferase reporter assay, qRT-PCR, Western blot, Cell proliferation, apoptosis, cell cycle assays |
24076586 |
MIRT054191 |
hsa-miR-29a-3p |
Immunohistochemistry, Luciferase reporter assay, qRT-PCR, Western blot |
26512921 |
MIRT054192 |
hsa-miR-29b-3p |
Immunofluorescence, Immunohistochemistry, Luciferase reporter assay, Northern blot, qRT-PCR, Western blot |
25428377 |
MIRT054192 |
hsa-miR-29b-3p |
Immunofluorescence, Luciferase reporter assay, qRT-PCR, Microarray, Western blot |
25263462 |
MIRT054193 |
hsa-miR-29c-3p |
Immunofluorescence, Immunohistochemistry, Luciferase reporter assay, Northern blot, qRT-PCR, Western blot |
25428377 |
MIRT437424 |
hsa-miR-137 |
PAR-CLIP |
20371350 |
MIRT437424 |
hsa-miR-137 |
Immunohistochemistry, Luciferase reporter assay, qRT-PCR, Western blot |
26102366 |
MIRT437424 |
hsa-miR-137 |
Luciferase reporter assay, qRT-PCR, Western blot |
24465609 |
MIRT437976 |
hsa-let-7g-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
25288334 |
MIRT437977 |
hsa-let-7b-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
25288334 |
MIRT438208 |
hsa-miR-302b-3p |
qRT-PCR, Western blot |
24337067 |
MIRT568545 |
hsa-miR-1273e |
PAR-CLIP |
20371350 |
MIRT568546 |
hsa-miR-92b-5p |
PAR-CLIP |
20371350 |
MIRT568547 |
hsa-miR-151b |
PAR-CLIP |
20371350 |
MIRT568548 |
hsa-miR-151a-5p |
PAR-CLIP |
20371350 |
MIRT568549 |
hsa-miR-3678-5p |
PAR-CLIP |
20371350 |
MIRT568550 |
hsa-miR-7845-5p |
PAR-CLIP |
20371350 |
MIRT568551 |
hsa-miR-4517 |
PAR-CLIP |
20371350 |
MIRT568552 |
hsa-miR-4753-5p |
PAR-CLIP |
20371350 |
MIRT568553 |
hsa-miR-6768-3p |
PAR-CLIP |
20371350 |
MIRT568554 |
hsa-miR-126-3p |
PAR-CLIP |
20371350 |
MIRT731613 |
hsa-miR-2861 |
Luciferase reporter assay, Western blot |
27364926 |
MIRT733721 |
hsa-miR-148a-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
27878305 |
MIRT734218 |
hsa-miR-143-3p |
Luciferase reporter assay, Microarray, qRT-PCR, Western blot |
28404925 |
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0001934 |
Process |
Positive regulation of protein phosphorylation |
ISS |
|
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
IBA |
21873635 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
IDA |
10983986, 16540465 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
TAS |
21432781 |
GO:0005515 |
Function |
Protein binding |
IPI |
10490823, 10983986, 12434148, 16417406, 16792529, 17030088, 19713527, 20059950, 20856200, 21291857, 21737686, 22939624, 23823123, 32296183 |
GO:0005524 |
Function |
ATP binding |
IDA |
16540465 |
GO:0005634 |
Component |
Nucleus |
IDA |
20059950 |
GO:0005634 |
Component |
Nucleus |
TAS |
21432781 |
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005654 |
Component |
Nucleoplasm |
TAS |
|
GO:0005769 |
Component |
Early endosome |
IEA |
|
GO:0005829 |
Component |
Cytosol |
IDA |
|
GO:0005829 |
Component |
Cytosol |
TAS |
|
GO:0005886 |
Component |
Plasma membrane |
ISS |
|
GO:0005886 |
Component |
Plasma membrane |
TAS |
21432781 |
GO:0005938 |
Component |
Cell cortex |
ISS |
|
GO:0005978 |
Process |
Glycogen biosynthetic process |
IEA |
|
GO:0006006 |
Process |
Glucose metabolic process |
IEA |
|
GO:0006417 |
Process |
Regulation of translation |
IEA |
|
GO:0006464 |
Process |
Cellular protein modification process |
TAS |
1409633 |
GO:0007165 |
Process |
Signal transduction |
TAS |
21432781 |
GO:0008284 |
Process |
Positive regulation of cell population proliferation |
IMP |
10983986 |
GO:0008286 |
Process |
Insulin receptor signaling pathway |
IMP |
16814735 |
GO:0008286 |
Process |
Insulin receptor signaling pathway |
TAS |
21432781 |
GO:0008643 |
Process |
Carbohydrate transport |
IEA |
|
GO:0010748 |
Process |
Negative regulation of long-chain fatty acid import across plasma membrane |
IMP |
16814735 |
GO:0010907 |
Process |
Positive regulation of glucose metabolic process |
IMP |
16814735 |
GO:0010918 |
Process |
Positive regulation of mitochondrial membrane potential |
IMP |
10983986 |
GO:0018105 |
Process |
Peptidyl-serine phosphorylation |
IBA |
21873635 |
GO:0030334 |
Process |
Regulation of cell migration |
TAS |
21432781 |
GO:0030335 |
Process |
Positive regulation of cell migration |
IDA |
25428377 |
GO:0031340 |
Process |
Positive regulation of vesicle fusion |
ISS |
|
GO:0032000 |
Process |
Positive regulation of fatty acid beta-oxidation |
IMP |
16814735 |
GO:0032287 |
Process |
Peripheral nervous system myelin maintenance |
IEA |
|
GO:0032587 |
Component |
Ruffle membrane |
ISS |
|
GO:0032869 |
Process |
Cellular response to insulin stimulus |
IMP |
16814735 |
GO:0032991 |
Component |
Protein-containing complex |
IDA |
10983986 |
GO:0035556 |
Process |
Intracellular signal transduction |
IBA |
21873635 |
GO:0043066 |
Process |
Negative regulation of apoptotic process |
IMP |
10983986 |
GO:0043231 |
Component |
Intracellular membrane-bounded organelle |
IDA |
|
GO:0045444 |
Process |
Fat cell differentiation |
TAS |
21432781 |
GO:0045725 |
Process |
Positive regulation of glycogen biosynthetic process |
IMP |
16814735 |
GO:0046326 |
Process |
Positive regulation of glucose import |
IMP |
16814735 |
GO:0046872 |
Function |
Metal ion binding |
IEA |
|
GO:0060644 |
Process |
Mammary gland epithelial cell differentiation |
TAS |
21432781 |
GO:0065002 |
Process |
Intracellular protein transmembrane transport |
ISS |
|
GO:0071156 |
Process |
Regulation of cell cycle arrest |
TAS |
21432781 |
GO:0071486 |
Process |
Cellular response to high light intensity |
IEA |
|
GO:0072659 |
Process |
Protein localization to plasma membrane |
IEA |
|
GO:0090314 |
Process |
Positive regulation of protein targeting to membrane |
ISS |
|
GO:0090630 |
Process |
Activation of GTPase activity |
IEA |
|
GO:0097473 |
Process |
Retinal rod cell apoptotic process |
IEA |
|
GO:0106310 |
Function |
Protein serine kinase activity |
IEA |
|
GO:0106311 |
Function |
Protein threonine kinase activity |
IEA |
|
GO:2000147 |
Process |
Positive regulation of cell motility |
IMP |
17332325 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P31751 |
Protein name |
RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) |
Protein function |
AKT2 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development.; One of the few specific substrates of AKT2 identified recently is PITX2. Phosphorylation of PITX2 impairs its association with the CCND1 mRNA-stabilizing complex thus shortening the half-life of CCND1. AKT2 seems also to be the principal isoform responsible of the regulation of glucose uptake. Phosphorylates C2CD5 on 'Ser-197' during insulin-stimulated adipocytes. AKT2 is also specifically involved in skeletal muscle differentiation, one of its substrates in this process being ANKRD2. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. Phosphorylates CLK2 on 'Thr-343'. |
PDB |
1GZK
,
1GZN
,
1GZO
,
1MRV
,
1MRY
,
1O6K
,
1O6L
,
1P6S
,
2JDO
,
2JDR
,
2UW9
,
2X39
,
2XH5
,
3D0E
,
3E87
,
3E88
,
3E8D
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00169 |
PH |
6 → 108 |
PH domain |
Domain |
PF00069 |
Pkinase |
152 → 409 |
Protein kinase domain |
Domain |
PF00433 |
Pkinase_C |
430 → 475 |
Protein kinase C terminal domain |
Family |
|
Sequence |
|
Sequence length |
481 |
Interactions |
View interactions |
|
|